HCA Healthcare, Inc. $HCA Shares Sold by Financial Strategies Group Inc.

Financial Strategies Group Inc. trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 25,097 shares of the company’s stock after selling 1,577 shares during the period. HCA Healthcare comprises about 2.2% of Financial Strategies Group Inc.’s portfolio, making the stock its 14th biggest position. Financial Strategies Group Inc.’s holdings in HCA Healthcare were worth $11,584,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of HCA. Brighton Jones LLC acquired a new position in shares of HCA Healthcare during the fourth quarter worth $1,021,000. NewEdge Advisors LLC increased its holdings in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after acquiring an additional 409 shares during the last quarter. Sivia Capital Partners LLC lifted its stake in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares during the last quarter. Janney Montgomery Scott LLC raised its holdings in HCA Healthcare by 4.5% during the second quarter. Janney Montgomery Scott LLC now owns 14,633 shares of the company’s stock worth $5,606,000 after purchasing an additional 636 shares in the last quarter. Finally, Capital Investment Advisors LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $234,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA opened at $488.19 on Friday. The business has a 50 day simple moving average of $481.07 and a 200-day simple moving average of $437.81. HCA Healthcare, Inc. has a 12 month low of $295.00 and a 12 month high of $527.55. The stock has a market capitalization of $111.40 billion, a P/E ratio of 17.20, a P/E/G ratio of 1.48 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.HCA Healthcare’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter last year, the company earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is 10.15%.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Strong quarterly results and market reaction — HCA reported an EPS beat and raised FY 2026 guidance, prompting coverage noting a gap up in the stock after the print. Shares Gap Up on Strong Earnings
• Positive Sentiment: Analysts boost targets and maintain bullish ratings — Goldman Sachs raised its price target to $558 (buy) and Leerink Partners increased its target to $573 (outperform), supporting further upside potential. Goldman Sachs Raises PT Leerink Raises PT TickerReport
• Positive Sentiment: Additional bullish analyst commentary — Truist and Deutsche Bank analysts publicly stated expectations for HCA shares to rise, reinforcing the buy-side momentum. Truist Note Deutsche Bank Note
• Positive Sentiment: Brand and quality recognition — Multiple HCA hospitals placed on Healthgrades’ America’s 50/100/250 Best Hospitals lists, supporting reputation and referral flows. Healthgrades Recognition
• Positive Sentiment: Outpatient growth and M&A runway — Company commentary and industry pieces highlight HCA’s push into outpatient facilities and acquisition opportunities, which investors view as margin‑accretive growth. Outpatient Growth Acquisition Opportunities
• Positive Sentiment: Bullish research notes/coverage — Zacks highlights HCA as a strong growth stock based on style scores, adding to favorable retail/institutional sentiment. Zacks Growth Stock Piece
• Neutral Sentiment: Analysts say the narrative is shifting — Coverage explores how the investment story is evolving post‑earnings/target resets; watch valuation vs. growth expectations. Analyst Narrative
• Neutral Sentiment: Local expansion and competitive landscape — Reporting on new ER builds and regional facility activity (e.g., southwest Florida) that may influence local market share dynamics. Local ER Story Freestanding EDs
• Negative Sentiment: Policy/regulatory risk — HCA is publicly noting it is monitoring federal policy shifts that could affect reimbursement or operations; this is a watcher for downside risk. Policy Risk

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

HCA has been the subject of several research analyst reports. KeyCorp set a $503.00 price objective on shares of HCA Healthcare in a research note on Wednesday. Mizuho lifted their price target on HCA Healthcare from $505.00 to $520.00 and gave the stock an “outperform” rating in a research report on Thursday, December 18th. Stephens raised their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Cantor Fitzgerald boosted their price target on HCA Healthcare from $525.00 to $588.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, The Goldman Sachs Group lifted their target price on HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday. Fifteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $518.76.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.